• Alto Neuroscience, Inc. Stock 12‑Month Price Target Cut to $34.8, Implies 33% Upside TradingView Thu, 09 Jul 2026 04:20:00 GMT
• ANRO Stock Drops 7% After Disappointing Schizophrenia Study Results – But Analyst Sees Dip As Attractive Entry Point Stocktwits Thu, 09 Jul 2026 03:55:16 GMT
• ANRO Stock Falls After Hours On Failed Schizophrenia Study Results Stocktwits Tue, 07 Jul 2026 22:03:45 GMT
• Alto Neuroscience (ANRO) Edges Lower as Shares Test Key Support Zone - Equity Put Call dars.gov.et Sun, 05 Jul 2026 23:47:32 GMT
• Price to earnings forward of Alto Neuroscience, Inc. – NYSE:ANRO TradingView Sat, 04 Jul 2026 03:49:48 GMT
• Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment? Yahoo Finance Thu, 02 Jul 2026 19:58:38 GMT
• 5 Best Up and Coming Pharmaceutical Stocks to Buy Now Insider Monkey Wed, 01 Jul 2026 04:55:00 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Tue, 30 Jun 2026 19:33:38 GMT
• Alto Neuroscience, Inc.(NYSE: ANRO) added to Russell 2000 Index marketscreener.com Mon, 29 Jun 2026 21:51:33 GMT
• Alto Neuroscience, Inc.(NYSE:ANRO) dropped from Russell Microcap Value Benchmark Index marketscreener.com Mon, 29 Jun 2026 16:38:28 GMT
• anro shareholder alert: bronstein, gewirtz and grossman, llc anno The National Law Review Sun, 28 Jun 2026 18:02:53 GMT
• Levi & Korsinsky Notifies Alto Neuroscience, Inc. (ANRO) Sharehol The National Law Review Sun, 28 Jun 2026 17:51:51 GMT
• ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc The National Law Review Sun, 28 Jun 2026 16:52:53 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Sun, 28 Jun 2026 12:18:41 GMT
• jonestrading maintains alto neuroscience(anro.us) with buy rating, maintains target price $44 富途牛牛 Sat, 27 Jun 2026 23:41:20 GMT
• skander mansouri vs anro nel • head to head Tennis Temple - Live tennis Sat, 27 Jun 2026 11:50:34 GMT
• H.C. Wainwright Remains a Buy on Alto Neuroscience, Inc. (ANRO) The Globe and Mail Fri, 26 Jun 2026 12:48:00 GMT
• Alto Neuroscience, Inc. Actuals & Estimates (BOATS:ANRO) TradingView Fri, 26 Jun 2026 12:38:23 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Fri, 26 Jun 2026 01:05:50 GMT
• H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $50 Moomoo Thu, 25 Jun 2026 13:34:00 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Wed, 24 Jun 2026 16:18:45 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Tue, 23 Jun 2026 18:38:33 GMT
• alto neuroscience inc (anro) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• anro stock falls after hours on failed schizophrenia study results Stocktwits Sun, 21 Jun 2026 05:04:28 GMT
• anro stock falls after hours on failed schizophrenia study results Stocktwits Fri, 19 Jun 2026 23:30:15 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Fri, 19 Jun 2026 16:37:07 GMT
• alto neuroscience inc (anro) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 09:27:41 GMT
• alto neuroscience inc (anro) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:46:54 GMT
• H.C. Wainwright reiterates Alto Neuroscience stock rating at buy By Investing.com Investing.com India Wed, 17 Jun 2026 11:51:06 GMT
• alto neuroscience inc (anro) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 08:38:33 GMT
• alto neuroscience (anro) surges 3.76% as biotech sector gains traction - eth profile dars.gov.et Wed, 17 Jun 2026 07:00:00 GMT
• alto neuroscience inc (anro) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 22:32:58 GMT
• alto neuroscience inc (anro) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 22:21:13 GMT
• alto neuroscience inc (anro) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 22:08:23 GMT
• alto neuroscience inc (anro) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 22:07:51 GMT
• ANRO Q1 2026 Earnings: Wider-Than-Expected Loss Per Share Amid Clinical Progress - Earnings Analysis dars.gov.et Tue, 16 Jun 2026 07:00:00 GMT
• Nature Medicine trial: pramipexole eased 'pleasure loss' in depression Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• JonesTrading Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $44 富途牛牛 Mon, 15 Jun 2026 07:00:00 GMT
• alto neuroscience inc (anro) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• alto neuroscience inc (anro) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 14 Jun 2026 07:00:00 GMT
• Alto Neuroscience Inc. (ANRO) Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Advances Pipeline - Cost Struct... dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• alto neuroscience (anro) edges higher amid consolidation near support levels - initial balance dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• anro q1 2026 earnings: clinical-stage biotech reports wider-than-expected loss, yet stock gains - special dividend alert newsline.com Fri, 12 Jun 2026 19:42:38 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Tue, 09 Jun 2026 16:34:05 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Mon, 08 Jun 2026 12:21:08 GMT
• alto neuroscience q1 2026 earnings: wider-than-expected loss pressures shares - earnings weakness phase newsline.com Sun, 07 Jun 2026 14:41:25 GMT
• anro q1 2026 earnings: wider-than-expected loss weighs on investor sentiment - earnings cycle outlook newsline.com Sat, 06 Jun 2026 18:48:15 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point Stocktwits Fri, 05 Jun 2026 23:13:33 GMT
• anro: three late-stage psychiatry programs expect pivotal data readouts in 2027 TradingView Wed, 03 Jun 2026 14:34:08 GMT
• alto neuroscience (anro) jefferies global healthcare conference 2026 summary Quartr Wed, 03 Jun 2026 07:00:00 GMT
• alto neuroscience (anro) edges lower as stock hovers near key support zone - index put call The Legal Advocate Sat, 30 May 2026 01:47:04 GMT
• Alto Neuroscience (ANRO) director Andrew Craig Miller files initial Form 3 Stock Titan Fri, 29 May 2026 07:00:00 GMT
• Alto Neuroscience (ANRO) director awarded 26,000 stock options at $20.44 strike price Stock Titan Fri, 29 May 2026 07:00:00 GMT
• alto neuroscience, inc. (anro) files 8-k report announcing no soliciting material or tender offers – company info & nyse listing –... Minichart Fri, 29 May 2026 07:00:00 GMT
• alto neuroscience (anro) edges lower as stock hovers near key support zone - momentum etf newsline.com Fri, 29 May 2026 07:00:00 GMT
• alto neuroscience, inc. (anro) files 8-k report announcing no soliciting material or tender offers – company info & nyse listing Minichart Thu, 28 May 2026 18:06:00 GMT
• h.c. wainwright maintains alto neuroscience(anro.us) with buy rating, maintains target price $50 富途牛牛 Thu, 28 May 2026 14:40:11 GMT
• $14b karuna sale r&d chief andrew miller joins alto board Stock Titan Thu, 28 May 2026 12:03:00 GMT
• Alto Neuroscience appoints Andrew Miller to board of directors Investing.com Thu, 28 May 2026 07:00:00 GMT
• alto neuroscience appoints karuna therapeutics founder andrew miller, ph.d. to board of directors Business Wire Thu, 28 May 2026 07:00:00 GMT
• biotech leader andrew miller joins alto neuroscience (anro) board and governance committee Stock Titan Thu, 28 May 2026 07:00:00 GMT
• alto neuroscience inc. (anro) faces 2.94% decline as stock tests support levels - risk reversal thelegaladvocate.com Wed, 27 May 2026 21:30:00 GMT
• h.c. wainwright reiterates alto neuroscience stock rating at buy Investing.com UK Wed, 27 May 2026 16:53:29 GMT
• h.c. wainwright maintains alto neuroscience(anro.us) with buy rating, maintains target price $50 Moomoo Wed, 27 May 2026 10:31:00 GMT
• Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors Business Wire Wed, 27 May 2026 07:00:00 GMT
• anro q1 2026 earnings: eps misses estimates as pre-revenue biotech advances pipeline - dividend cut risk The Legal Advocate Sun, 24 May 2026 00:46:00 GMT
• bofa securities maintains alto neuroscience(anro.us) with buy rating, cuts target price to $33 富途牛牛 Sat, 23 May 2026 11:05:01 GMT
• wolfe research initiates alto neuroscience stock with outperform rating Investing.com India Sat, 23 May 2026 07:04:34 GMT
• anro q1 2026 earnings: eps misses estimates as pre-revenue biotech advances pipeline - ebitda estimate trend newsline.com Sat, 23 May 2026 07:00:00 GMT
• anro q1 2026 earnings: eps misses estimates as clinical-stage biotech continues investment in pipeline The Legal Advocate Sat, 23 May 2026 07:00:00 GMT
• alto neuroscience analyst ratings and price targets | nyse:anro Benzinga Fri, 22 May 2026 21:21:00 GMT
• wolfe research initiates alto neuroscience stock with outperform rating by investing.com Investing.com Canada Fri, 22 May 2026 10:51:28 GMT
• bofa securities maintains alto neuroscience(anro.us) with buy rating, cuts target price to $33 Moomoo Fri, 22 May 2026 09:31:00 GMT
• anro q1 2026 earnings: eps misses estimates but shares climb on pipeline hopes - revenue surprise history newsline.com Fri, 22 May 2026 07:00:00 GMT
• alto neuro (anro) gained +0.67% — can it break $21.97? 2026-05-21 - community exit signals Newser Thu, 21 May 2026 14:33:09 GMT
• anro stock price, quote & chart | alto neuroscience inc (nyse:anro) ChartMill Thu, 21 May 2026 07:00:00 GMT
• alto neuro (anro) declines -6.19% amid market weakness 2026-05-19 - add alert newsline.com Tue, 19 May 2026 07:00:00 GMT
• alto neuro (anro) q1 2026 results fall short — eps $-0.80, revenue $n/a - {璐㈡姤鍓爣棰榼 Newser Mon, 18 May 2026 17:45:29 GMT
• baird maintains alto neuroscience(anro.us) with buy rating, cuts target price to $36 Moomoo Mon, 18 May 2026 12:31:00 GMT
• analysts offer insights on healthcare companies: alto neuroscience, inc. (anro) and radnet (rdnt) The Globe and Mail Fri, 15 May 2026 15:36:00 GMT
• mental health scientist wins columbia transformational research award Stock Titan Fri, 15 May 2026 12:27:00 GMT
• Alto Neuroscience (ANRO) CEO gifts 400,000 shares to family trust Stock Titan Fri, 15 May 2026 07:00:00 GMT
• Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award Business Wire Fri, 15 May 2026 07:00:00 GMT
• jonestrading maintains alto neuroscience(anro.us) with buy rating, maintains target price $44 富途牛牛 Fri, 15 May 2026 07:00:00 GMT
• alto neuroscience (anro) vestal point reports 6.5% ownership Stock Titan Fri, 15 May 2026 07:00:00 GMT
• point72 affiliates, steven a. cohen hold 3.7% of alto neuroscience (anro) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• [schedule 13g/a] alto neuroscience, inc. amended passive investment disclosure Stock Titan Fri, 15 May 2026 07:00:00 GMT
• sirenia, alex silverstein disclose 7.9% stake in alto neuroscience (anro) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• jefferies maintains alto neuroscience(anro.us) with buy rating, maintains target price $35 Moomoo Thu, 14 May 2026 21:40:15 GMT
• a quick look at today's ratings for alto neuroscience(anro.us), with a forecast between $24 to $28 Moomoo Thu, 14 May 2026 13:41:13 GMT
• York Gwill receives 10,958 Alto Neuroscience (ANRO) stock options grant Stock Titan Thu, 14 May 2026 07:00:00 GMT
• alto neuroscience (anro) director receives 10,958-share stock option grant Stock Titan Thu, 14 May 2026 07:00:00 GMT
• alto neuroscience (anro) director awarded 10,958 stock options as compensation Stock Titan Thu, 14 May 2026 07:00:00 GMT
• alto neuroscience (anro) director gets 10,958 options at $24.63 strike Stock Titan Thu, 14 May 2026 07:00:00 GMT
• alto neuroscience (nasdaq: anro) director receives 10,958 stock option grant Stock Titan Thu, 14 May 2026 07:00:00 GMT
• anro: alto-207 demonstrates robust efficacy in trd, with late-stage trials and major catalysts ahead TradingView Thu, 14 May 2026 00:56:00 GMT
• alto raises $120m to advance treatment‑resistant depression drug Stock Titan Wed, 13 May 2026 11:03:00 GMT
• Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights Business Wire Wed, 13 May 2026 07:00:00 GMT
• Alto Neuroscience, Inc. Stock 12‑Month Price Target Raised to $35.52, Implies 44% Upside TradingView Wed, 13 May 2026 07:00:00 GMT
• alto neuroscience reports q1 2026 net loss of $26.2m, cash of $264.2m after $120m pipe TradingView Wed, 13 May 2026 07:00:00 GMT
• alto neuroscience shareholders shape governance and equity plans TipRanks Wed, 13 May 2026 07:00:00 GMT
• anro: alto-207 demonstrates robust efficacy in trd, with late-stage trials and major catalysts ahead TradingView Wed, 13 May 2026 07:00:00 GMT
• alto neuroscience (nyse: anro) boosts cash with $120m pipe and funds runway to 2029 Stock Titan Wed, 13 May 2026 07:00:00 GMT
• [10-q] alto neuroscience, inc. quarterly earnings report Stock Titan Wed, 13 May 2026 07:00:00 GMT
• alto neuroscience (anro) oks espp amendment but rejects equity plan change Stock Titan Wed, 13 May 2026 07:00:00 GMT
• earnings flash (anro) alto neuroscience posts q1 loss $0.80 a share, vs. factset est of $0.56 loss marketscreener.com Wed, 13 May 2026 07:00:00 GMT
• alto neuroscience: runway to fund planned operations through 2029 >anro Moomoo Wed, 13 May 2026 07:00:00 GMT
• Alto Neuroscience Announces Participation in Upcoming Investor Conferences Business Wire Mon, 11 May 2026 07:00:00 GMT
• alto neuroscience brings neuropsychiatric medicines to investor forums Stock Titan Mon, 11 May 2026 07:00:00 GMT
• the hidden strength in alto neuro (anro) most investors miss (slow drop) 2026-05-11 - statistical arbitrage newsline.com Mon, 11 May 2026 07:00:00 GMT
• alto neuroscience (nyse:anro) rating increased to hold at wall street zen MarketBeat Sat, 09 May 2026 07:00:00 GMT
• the edge alto neuro (anro) has in a competitive landscape (flirts with breakout) 2026-05-08 - liquidity sweep The Legal Advocate Fri, 08 May 2026 07:00:00 GMT
• anro stock price, quote & chart | alto neuroscience inc (nyse:anro) ChartMill Fri, 08 May 2026 07:00:00 GMT
• alto neuroscience (anro) projected to post earnings on wednesday MarketBeat Wed, 06 May 2026 07:00:00 GMT
• bofa securities initiates alto neuroscience(anro.us) with buy rating, announces target price $35 富途牛牛 Tue, 05 May 2026 09:02:05 GMT
• bofa securities initiated coverage on alto neuroscience with a new price target Quantisnow Tue, 05 May 2026 07:00:00 GMT
• bank of america begins coverage on alto neuroscience (nyse:anro) MarketBeat Tue, 05 May 2026 07:00:00 GMT
• alto neuroscience (anro) price target increased by 81.11% to 19.09 MSN Tue, 05 May 2026 05:20:05 GMT
• bofa securities initiates alto neuroscience(anro.us) with buy rating, announces target price $35 Moomoo Mon, 04 May 2026 21:58:17 GMT
• in a 32-patient depression trial, alto's alto-207 beat placebo Stock Titan Mon, 04 May 2026 12:03:00 GMT
• alto neuroscience presents phase 2a data for alto-207 in major depressive disorder at sobp annual meeting Business Wire Mon, 04 May 2026 07:00:00 GMT
• bofa initiates alto neuroscience stock coverage with buy rating Investing.com Mon, 04 May 2026 07:00:00 GMT
• alto neuroscience reports positive phase 2a depression trial by investing.com Investing.com Canada Mon, 04 May 2026 07:00:00 GMT
• anro (alto neuro) q4 2025 eps trails estimates by 7.1 percent, sending shares down 0.69 percent today. - annual report newsline.com Wed, 29 Apr 2026 07:00:00 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point MSN Wed, 29 Apr 2026 04:17:07 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point MSN Tue, 28 Apr 2026 21:57:35 GMT
• alto neuroscience (anro) price target increased by 15.20% to 36.72 MSN Tue, 28 Apr 2026 05:53:37 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point MSN Mon, 27 Apr 2026 20:37:30 GMT
• why alto neuro (anro) stock is trending (weakens) 2026-04-27 - aaii bullish newsline.com Mon, 27 Apr 2026 07:00:00 GMT
• anro stock drops 7% after disappointing schizophrenia study results – but analyst sees dip as attractive entry point MSN Sun, 26 Apr 2026 07:47:11 GMT
Alto Neuroscience Inc(NYSE:ANRO) 
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatone...
Website: https://altoneuroscience.com/
Founded: 2019
CEO / Founder: Amit Etkin
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends